Choong-wae to initiate phase 3 trial of avanafil for treatment of erectile dysfunction

Published: 2009-02-17 06:58:00

Updated: 2009-02-17 06:58:00

Choong-wae Pharm said on November 13 that it will conduct phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED) under the recent approval of the Korea Food and Drug Administration. Avanafil is a next-generation, fast-acting, selective, investigatio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK